Pharmicell Co (XKRX:005690) Accounts Payable : ₩3,007 Mil (As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Accounts Payable?

Pharmicell Co's Accounts Payable for the quarter that ended in Mar. 2024 was ₩3,007 Mil.

Pharmicell Co's quarterly Accounts Payable declined from Sep. 2023 (₩2,578 Mil) to Dec. 2023 (₩1,777 Mil) but then increased from Dec. 2023 (₩1,777 Mil) to Mar. 2024 (₩3,007 Mil).

Pharmicell Co's annual Accounts Payable increased from Dec. 2021 (₩838 Mil) to Dec. 2022 (₩2,656 Mil) but then declined from Dec. 2022 (₩2,656 Mil) to Dec. 2023 (₩1,777 Mil).

Pharmicell Co Accounts Payable Historical Data

The historical data trend for Pharmicell Co's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Accounts Payable Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

600.13

1,971.84

837.77

2,655.62

1,776.57

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable	Get a 7-Day Free Trial															2,934.01	1,836.26	2,577.94	1,776.57	3,007.38

Pharmicell Co Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Pharmicell Co Accounts Payable Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines